
Rahika 200mg Tablet
Marketer
Novartis India Ltd
Salt Composition
Capmatinib (200mg)
Overview Rahika 200mg Tablet
Oncaspar 200mg tablets are indicated for non-small cell lung carcinoma management. This medication inhibits or reduces the proliferation of cancerous cells. Oncaspar 200mg tablets can be administered with or without food, ideally at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, depending on your specific condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen. Incorrect usage or exceeding the recommended dosage may lead to serious adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue only upon medical advice. Common side effects include swelling, nausea, muscle and joint pain, tiredness, vomiting, shortness of breath, cough, and reduced appetite. Serious side effects warranting immediate medical attention include profound fatigue, pruritus, jaundice, thoracic pain or discomfort, and cardiac arrhythmias. Liver and blood glucose monitoring via blood tests may be conducted before and during treatment. Inform your physician of any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial medications before commencing treatment. Numerous drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation. Reliable contraception is crucial for both partners throughout the treatment period to prevent conception.
Uses of Rahika 200mg Tablet
Managing Non-small Cell Lung Carcinoma
Major Benefits of Rahika 200mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rahika 200mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Rahika 200mg Tablet:
- Edema (swelling)
- Nausea
- Musculoskeletal stiffness
- Breathlessness
- Fatigue
- Vomiting
- Cough
- Decreased appetite
How to use Rahika 200mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rahika 200mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Rahika 200mg Tablet works:
Rahika 200mg Tablets inhibit a rogue protein responsible for cancer cell proliferation, thereby curbing or halting tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Rahika 200mg Tablet is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rahika 200mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Rahika 200mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Rahika 200mg Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Rahika 200mg tablets are considered safe, and no dosage alteration is necessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Rahika 200mg tablets; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Rahika 200mg Tablet :
Should you forget a Rahika 200mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rahika 200mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Protein synthesis blockers |
